Baxter EBITDA 2010-2023 | BAX
Baxter annual and quarterly EBITDA history from 2010 to 2023. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Baxter EBITDA for the quarter ending December 31, 2023 was $0.596B, a 3.65% increase year-over-year.
- Baxter EBITDA for the twelve months ending December 31, 2023 was $1.730B, a 24.55% decline year-over-year.
- Baxter 2023 annual EBITDA was $1.73B, a 24.55% decline from 2022.
- Baxter 2022 annual EBITDA was $2.293B, a 3.43% increase from 2021.
- Baxter 2021 annual EBITDA was $2.217B, a 9.73% decline from 2020.
| Baxter Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $1,730 |
| 2022 | $2,293 |
| 2021 | $2,217 |
| 2020 | $2,456 |
| 2019 | $2,592 |
| 2018 | $2,355 |
| 2017 | $2,038 |
| 2016 | $1,545 |
| 2015 | $1,208 |
| 2014 | $1,448 |
| 2013 | $1,131 |
| 2012 | $3,482 |
| 2011 | $3,616 |
| 2010 | $2,821 |
| 2009 | $3,515 |
| Baxter Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2023-12-31 | $596 |
| 2023-09-30 | $337 |
| 2023-06-30 | $292 |
| 2023-03-31 | $505 |
| 2022-12-31 | $575 |
| 2022-09-30 | $568 |
| 2022-06-30 | $607 |
| 2022-03-31 | $543 |
| 2021-12-31 | $245 |
| 2021-09-30 | $719 |
| 2021-06-30 | $646 |
| 2021-03-31 | $607 |
| 2020-12-31 | $619 |
| 2020-09-30 | $679 |
| 2020-06-30 | $550 |
| 2020-03-31 | $608 |
| 2019-12-31 | $745 |
| 2019-09-30 | $698 |
| 2019-06-30 | $574 |
| 2019-03-31 | $575 |
| 2018-12-31 | $571 |
| 2018-09-30 | $581 |
| 2018-06-30 | $579 |
| 2018-03-31 | $624 |
| 2017-12-31 | $476 |
| 2017-09-30 | $484 |
| 2017-06-30 | $531 |
| 2017-03-31 | $547 |
| 2016-12-31 | $504 |
| 2016-09-30 | $390 |
| 2016-06-30 | $274 |
| 2016-03-31 | $377 |
| 2015-12-31 | $344 |
| 2015-09-30 | $308 |
| 2015-06-30 | $277 |
| 2015-03-31 | $279 |
| 2014-12-31 | $391 |
| 2014-09-30 | $320 |
| 2014-06-30 | $912 |
| 2014-03-31 | $908 |
| 2013-12-31 | $608 |
| 2013-09-30 | $861 |
| 2013-06-30 | $1,011 |
| 2013-03-31 | $898 |
| 2012-12-31 | $701 |
| 2012-09-30 | $956 |
| 2012-06-30 | $957 |
| 2012-03-31 | $868 |
| 2011-12-31 | $792 |
| 2011-09-30 | $921 |
| 2011-06-30 | $1,000 |
| 2011-03-31 | $903 |
| 2010-12-31 | $702 |
| 2010-09-30 | $953 |
| 2010-06-30 | $867 |
| 2010-03-31 | $299 |
| 2009-12-31 | $905 |
| 2009-09-30 | $896 |
| 2009-06-30 | $901 |
| 2009-03-31 | $813 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $20.785B | $14.813B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $185.474B | 24.35 |
| Stryker (SYK) | United States | $128.161B | 31.78 |
| Boston Scientific (BSX) | United States | $106.966B | 34.07 |
| Medtronic (MDT) | Ireland | $106.730B | 15.11 |
| EssilorLuxottica (ESLOY) | France | $99.574B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.648B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.127B | 29.82 |
| ResMed (RMD) | United States | $27.032B | 27.03 |
| Terumo (TRUMY) | Japan | $25.476B | 35.98 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.896B | 16.03 |
| Koninklijke Philips (PHG) | Netherlands | $19.474B | 15.53 |
| Insulet (PODD) | United States | $11.711B | 61.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.741B | 0.00 |
| Demant (WILYY) | Denmark | $9.943B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.934B | 23.64 |
| BellRing Brands (BRBR) | United States | $7.285B | 39.17 |
| Lantheus Holdings (LNTH) | United States | $4.470B | 11.54 |
| Haemonetics (HAE) | United States | $4.379B | 22.40 |
| Perrigo (PRGO) | Ireland | $4.232B | 12.10 |
| GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
| Envista Holdings (NVST) | United States | $3.485B | 13.26 |
| Prestige Consumer Healthcare (PBH) | United States | $3.482B | 16.46 |
| QuidelOrtho (QDEL) | United States | $2.730B | 9.91 |
| Neogen (NEOG) | United States | $2.679B | 25.77 |
| Green Thumb Industries (GTBIF) | United States | $2.630B | 83.33 |
| ICU Medical (ICUI) | United States | $2.357B | 17.58 |
| TG Therapeutics (TGTX) | United States | $2.161B | 699.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.928B | 0.00 |
| Owens & Minor (OMI) | United States | $1.895B | 18.19 |
| Verano Holdings (VRNOF) | United States | $1.790B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.780B | 0.00 |
| InMode (INMD) | Israel | $1.458B | 7.55 |
| LeMaitre Vascular (LMAT) | United States | $1.437B | 47.43 |
| National Vision Holdings (EYE) | United States | $1.388B | 43.24 |
| AdaptHealth (AHCO) | United States | $1.300B | 9.78 |
| Warby Parker (WRBY) | United States | $1.287B | 0.00 |
| AtriCure (ATRC) | United States | $1.115B | 0.00 |
| MacroGenics (MGNX) | United States | $0.982B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.899B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.779B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.712B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.693B | 14.98 |
| Evolus (EOLS) | United States | $0.666B | 0.00 |
| Quanterix (QTRX) | United States | $0.613B | 0.00 |
| Jin Medical (ZJYL) | China | $0.547B | 0.00 |
| Valneva SE (VALN) | France | $0.540B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.509B | 11.02 |
| PetIQ (PETQ) | United States | $0.487B | 18.17 |
| TerrAscend (TSNDF) | Canada | $0.478B | 0.00 |
| ZimVie (ZIMV) | United States | $0.430B | 26.35 |
| OraSure Technologies (OSUR) | United States | $0.421B | 6.96 |
| Biote (BTMD) | United States | $0.417B | 3.96 |
| Aurora Cannabis (ACB) | Canada | $0.393B | 0.00 |
| Surmodics (SRDX) | United States | $0.371B | 40.11 |
| Zynex (ZYXI) | United States | $0.361B | 41.59 |
| Viemed Healthcare (VMD) | United States | $0.314B | 31.11 |
| Cerus (CERS) | United States | $0.301B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.280B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.274B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.241B | 14.70 |
| Organigram Holdings (OGI) | Canada | $0.199B | 0.00 |
| Veru (VERU) | United States | $0.193B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.192B | 0.00 |
| Omeros (OMER) | United States | $0.176B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.163B | 0.00 |
| High Tide (HITI) | Canada | $0.160B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.159B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.134B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.130B | 65.20 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.74 |
| InterCure (INCR) | Israel | $0.122B | 20.54 |
| Fonar (FONR) | United States | $0.102B | 8.80 |
| Cellectar Biosciences (CLRB) | United States | $0.099B | 0.00 |
| MariMed (MRMD) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.088B | 0.00 |
| Brainsway (BWAY) | Israel | $0.084B | 0.00 |
| Safety Shot (SHOT) | United States | $0.081B | 0.00 |
| Chimerix (CMRX) | United States | $0.081B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.060B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.86 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 15.04 |
| Bright Green (BGXX) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Flora Growth (FLGC) | United States | $0.020B | 0.00 |
| Agape ATP (ATPC) | $0.020B | 0.00 | |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 72.54 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.001B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |